Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
CNMD · against 596 other Healthcare companies listed in US-listed
Ranked #426 of 597 · scores higher than 29% of peers · safety percentile 20
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)57 peers with a safety percentile of 20–29, including CNMD · Click a bar to see the companies
Mainly because of its debt / equity, current ratio and beta, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | CNMD | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 523 reported | 0.80× | 0.23× | 25% | 33% | |
| BetaLower is better · 555 reported | 0.94 | 0.95 | 51% | 33% | |
| Current ratioHigher is better · 600 reported | 1.48× | 3.91× | 17% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.4B USD | 100 | 53 | |
| 1 | 6.4B USD | 100 | 45 | |
| 3 | 176M USD | 100 | 52 | |
| 4 | 1.4B USD | 100 | 44 | |
| 5 | 1.1B USD | 100 | 40 | |
| 422 | 3.2B USD | 21 | 46 | |
| 423 | 101.0B USD | 20 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 67 |
| 424 | 9.4B USD | 20 | 47 |
| 425 | 1.3B USD | 20 | 75 |
| 426 | 1.6B USD | 20 | 41 |
| 427 | 31.9B USD | 20 | 63 |
| 428 | 304M USD | 20 | 26 |
| 429 | 13.9B USD | 20 | 59 |
| 430 | 215M USD | 20 |